BREATHE BIOMEDICAL

Serial Number 97345649
602

Registration Progress

Application Filed
Apr 4, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

BREATHE BIOMEDICAL

Basic Information

Serial Number
97345649
Filing Date
April 4, 2022
Abandonment Date
July 10, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Dec 9, 2024
Classes
044

Rights Holder

Picomole Inc.

03
Address
191 Halifax St.
Moncton, New Brunswick E1C9R6
CA

Ownership History

Picomole Inc.

Original Applicant
03
Moncton, New Brunswick CA

Legal Representation

Attorney
Heather Balmat

USPTO Deadlines

All Deadlines Cleared

All 7 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

41 events
Date Code Type Description Documents
Dec 9, 2024 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Dec 9, 2024 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Apr 5, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Apr 5, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jan 9, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 9, 2024 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jan 9, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 5, 2024 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Jan 4, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 3, 2024 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Jan 3, 2024 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Jan 3, 2024 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Dec 1, 2023 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Dec 1, 2023 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Oct 6, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Oct 6, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Oct 6, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Oct 4, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 4, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 4, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 6, 2023 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Loading...
Jul 5, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 5, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jul 5, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 5, 2023 IUAA P USE AMENDMENT ACCEPTED Loading...
Jul 1, 2023 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jul 1, 2023 IUAF S USE AMENDMENT FILED Loading...
Jun 30, 2023 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Jun 29, 2023 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Jun 29, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 29, 2023 PETG O PETITION TO REVIVE-GRANTED Loading...
Jun 29, 2023 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
May 11, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
May 11, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
May 11, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jan 20, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 20, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 20, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 20, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 8, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 7, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Medical services; consulting services relating to health care providers in the field of treating life-changing or life-threatening diseases; healthcare services, namely, providing medical information, health related consultancy, and advisory services related to health using artificial intelligence, machine learning, and data analysis in the fields of biomarker information services, and disease diagnosis; health advice and information services; medical health assessment services; health screening services in the field of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; diagnostic health screening services in the field of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring and reporting services
First Use Anywhere: Jun 28, 2022
First Use in Commerce: Oct 18, 2022

Classification

International Classes
044